<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02065193</url>
  </required_header>
  <id_info>
    <org_study_id>China SCORE study</org_study_id>
    <nct_id>NCT02065193</nct_id>
  </id_info>
  <brief_title>Prevalence of Autism Spectrum Conditions in Mainland China</brief_title>
  <acronym>China SCORE</acronym>
  <official_title>Social Communication Research and Epidemiological Study in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cambridge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>China Disabled Persons Federation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cambridge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The China SCORE study is a prevalence study of Autism Spectrum Conditions (ASC) in 14 regions
      in mainland China. It will include the following steps:

        1. Large population-based screening This study will be conducted in urban areas but not
           rural areas across mainland China. One city of each region will participate, and in
           total there will be 14 cities for screening. Within each city, a number of 40 to 60
           ordinary primary schools will be randomly selected from the defined region. All the
           students who are in 1st to 4th grade will asked to participate in order to form a sample
           of approximately 20,000 students.

           Screening questionnaires The screening pack includes the Chinese CAST, the AQ-Child, the
           AQ-Adult short version (10 items), and risk factors questionnaire. An information sheet
           and consent form will be included in the pack as well.

        2. Further assessments We expect approximately 5% on the CAST will score positive in
           ordinary school population. Thus, for a 20,000 sample, we would expect 900 positives
           (90% response rate). All the screen-positives and a random selected 5% from borderline
           group will be invited for clinical assessment. The diagnosis of clinical assessment will
           be divided into three categories: definite ASC, suspected ASC, and non-ASC. Then all the
           children with clinical assessment results as definite ASC and suspected ASC and a
           randomly selected 10-20 non-ASC will be invited for research diagnostic assessment using
           the ADOS and ADI-R, as well as RPM as IQ test. After that, the consensus diagnosis
           between ADOS/ADI-R assessment and the clinical diagnosis will be the final diagnosis.

        3. Case identification in special schools All the children in special schools or training
           institutes in study region will be asked to fill in the screening pack. The children who
           do not attend any ordinary or special schools will be identified according to their
           residential ID in the studied regions. All screen-positives in special education will be
           assessed using the ADOS and ADI-R. Then those who met the criteria of ASC on ADOS or/and
           ADI-R will be assessed by psychiatrists and the clinical diagnosis will be the final
           diagnosis.

      If we combine the prevalence of ordinary schools and special schools together, we will get an
      estimate of the prevalence of ASC in school-population in China. If we combine all the cases
      identified from schools and from residential records, we will generate an estimate of the
      prevalence of ASC in the general population in mainland China.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Three-staged consensus diagnosis</measure>
    <time_frame>The assessments will be finished in one year.</time_frame>
    <description>The prevalence of Autism Spectrum Conditions will be measured using screening and diagnostic instruments including the Childhood Autism Spectrum Test , the Autism Diagnostic Observation Schedule, the Autism Diagnostic Interview-Revised, and Clinical diagnosis.</description>
  </primary_outcome>
  <number_of_groups>14</number_of_groups>
  <enrollment type="Anticipated">280000</enrollment>
  <condition>Autism Spectrum Conditions/Disorders</condition>
  <arm_group>
    <arm_group_label>Beijing group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Guangdong group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Shenzhen group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Shanxi group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Liaoning group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Jilin group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Heilongjiang group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Jiangsu group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Zhejiang group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Fujian group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Henan group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hubei group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hunan group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>'Shanxi group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ADOS/ADI-R/Clinical assessment</intervention_name>
    <arm_group_label>Beijing group</arm_group_label>
    <arm_group_label>Guangdong group</arm_group_label>
    <arm_group_label>Shenzhen group</arm_group_label>
    <arm_group_label>Shanxi group</arm_group_label>
    <arm_group_label>Liaoning group</arm_group_label>
    <arm_group_label>Jilin group</arm_group_label>
    <arm_group_label>Heilongjiang group</arm_group_label>
    <arm_group_label>Jiangsu group</arm_group_label>
    <arm_group_label>Zhejiang group</arm_group_label>
    <arm_group_label>Fujian group</arm_group_label>
    <arm_group_label>Henan group</arm_group_label>
    <arm_group_label>Hubei group</arm_group_label>
    <arm_group_label>Hunan group</arm_group_label>
    <arm_group_label>'Shanxi group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population in each city is a defined region, usually a district or two districts. We
        focus on urban populations in this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All children who are in study region will be recruited for this study.

          -  All children aged 6-11 years old.

        Exclusion Criteria:

          -  Children who are not in the study region.

          -  Children who are not found from ordinary schools, private training centres, public
             special schools and community household with the help of local residence records will
             not be included for this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol Brayne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon Baron-Cohen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carrie Allison, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hong You, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Disabled Persons Federation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jibin Han, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Disabled Persons Federation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sian Griffiths, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huso Yi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiang Sun, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cambridge/CUHK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fiona E Matthews, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MRC Biostatistics Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bonnie Auyeung, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiang Sun, PhD</last_name>
    <email>xs227@medschl.cam.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiang Sun</last_name>
    <email>sophiasunx@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fujian CDPF</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiulan Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenzhen CDPF</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenzhong Mao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heilongjiang CDPF</name>
      <address>
        <city>Jiamusi</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Peng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Luoyang CDPF</name>
      <address>
        <city>Luoyang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanwei Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hengyang CDPF</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengrong Dai</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jilin Mingzhi Centre</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Liaoning CDPF</name>
      <address>
        <city>Benxi</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donghong Su</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi CDPF</name>
      <address>
        <city>Changzhi</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiaqiu Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi CDPF</name>
      <address>
        <city>Xian</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaofei Gao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing CDPF</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guangdong CDPF</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianrong Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang CDPF</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuwen Hua</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hubei CDPF</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qin Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu CDPF</name>
      <address>
        <city>Yangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yue Zhang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2014</study_first_submitted>
  <study_first_submitted_qc>February 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2014</study_first_posted>
  <last_update_submitted>February 14, 2014</last_update_submitted>
  <last_update_submitted_qc>February 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Sophia Xiang Sun</investigator_full_name>
    <investigator_title>Cambridge-CUHK International Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

